1 / 13

UOG Journal Club: July 2013

UOG Journal Club: July 2013. Intrafetal laser treatment for twin reversed arterial perfusion sequence : cohort study and meta-analysis G. Pagani , F. D’Antonio, A. Khalil , A. Papageorghiou , A. Bhide and B. Thilaganathan Volume 42, Issue 1, Date: July 2013, pages 6–14 .

sai
Télécharger la présentation

UOG Journal Club: July 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UOG Journal Club: July 2013 Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis G. Pagani, F. D’Antonio, A. Khalil, A. Papageorghiou, A. Bhide and B. Thilaganathan Volume 42, Issue 1, Date: July 2013, pages 6–14 Journal Club slides prepared by Dr. Katherine Goetzinger (UOG Editor for Trainees)

  2. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 • Twin reversed arterial perfusion (TRAP) sequence is a unique complication of monochorionic twins • TRAP sequence is characterized by retrograde perfusion of an acardiac mass by a normal (pump) twin through placental arterioarterial anastomoses • TRAP sequence results in a hyperdynamic circulation and high output cardiac failure of the pump twin • The goal of antenatal management has been to prevent demise of the pump twin by intrauterine therapy when cardiac strain of the pump twin or increased growth of the acardiac twin occurs

  3. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Objectives • To ascertain the outcome of TRAP cases managed either expectantly or with intrafetal laser therapy in a single center • To systematically review the literature to assess outcomes of TRAP cases treated with intrafetal laser therapy

  4. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Methodology Retrospective Cohort Study • Inclusion Criteria: All TRAP cases identified from 2000-2012 • Exposure: Expectant management vsfetal laser when indicated • Fetal laser indicated by rapid growth of the TRAP mass, development of a hyperdynamic circulation, or cardiac strain in the pump twin • Outcomes: Fetal loss, gestational age at demise, GA at live birth, birth weight, gestational age interval from treatment to delivery

  5. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Methodology Systematic Review & Meta-Analysis • Inclusion Criteria: Studies reporting the outcome of TRAP cases treated by laser therapy • Outcomes: Overall survival and preterm birth • Analysis: • Forest plots: fixed and random effects models • Between-study heterogeneity: Higgin’s I2 • Publication bias: Funnel plots and Begg and Mazumdar’s rank correlation test • Cases stratified by gestational age at therapy (<16 vs ≥16 weeks)

  6. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Results Retrospective Cohort Data presented as n (%) or median.

  7. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Results: Systematic Review Potentially appropriate studies identified from search (n = 81) Citations excluded based on title or abstract (n = 58) Citations retrieved for detailed evaluation of manuscript (n = 23) Studies excluded (n = 13) Studies included in systematic review (n = 10) These 10 studies included 34 pregnancies complicated by TRAP sequence which were treated by intrafetal laser

  8. Study n/N Jolly 2001 1.00 (0.16, 1.00) 2/2 Soothill 2002 1.00 (0.16, 1.00) 2/2 Sepulveda 2004 1.00 (0.03, 1.00) 1/1 Weisz 2004 1.00 (0.16, 1.00) 2/2 6/10 O'Donoghue 2008 0.60 (0.26, 0.88) 1/1 Cavoretto 2009 1.00 (0.03, 1.00) Sepulveda 2009 1.00 (0.16, 1.00) 2/2 5/6 Lewi 2010 0.83 (0.36, 1.00) Scheier 2011 0.86 (0.42, 1.00) 6/7 Wegrzyn 2012 1.00 (0.03, 1.00) 1/1 This study 0.82 (0.57, 0.96) 14/17 Combined 0.80 (0.69, 0.89) 42/51 0.0 0.2 0.4 0.6 0.8 1.0 I2 = 0% (95% CI = 0% to 51.2%) Proportion (95% confidence interval) Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Results: Systematic Review The overall neonatal survival after intrafetal laser treatment was 80% (95% CI, 69–89%) There was no significant heterogeneity between studies (I2 = 0%)

  9. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Results: Systematic Review • The overall risk of PTB <37 weeks was 40% (95% CI, 27– 59%) with no evidence of statistically significant heterogeneity (I2 = 24.8%) • The overall risk of PTB <32 weeks was 7% (95% CI, 4–21%) • Adverse pregnancy outcome (fetal demise and PTB <37 weeks) was significantly lower (p=0.0025) when treatment occurred <16 weeks (19%) compared ≥16 weeks (66%)

  10. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Results: Systematic Review Neonatal survival P = 0.19 PTB <37 weeks P = 0.10 No evidence of significant publication bias

  11. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Conclusions • Expectant management of TRAP sequence has a high fetal loss rate • Serial ultrasound and Doppler monitoring is ineffective at identifying TRAP cases at high risk of fetal demise • Early intervention with intrafetal laser treatment may improve pregnancy outcomes in cases of TRAP, especially if performed prior to 16 weeks Implications for practice • Routine intrafetal laser therapy prior to 16 weeks’ gestation should be considered in pregnancies affected by TRAP sequence in order to reduce associated adverse pregnancy outcomes

  12. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Strengths Limitations • No randomized comparison group • Use of composite outcome in stratified analysis • Potential for publication bias • Variable quality of studies included with none reporting efforts to reduce bias • Range of laser technique and experience between studies is likely • Large series of cases • Meta-analysis to overcome sample size issues • Stratified analysis performed based on gestational age • No significant heterogeneity between studies

  13. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis Pagani et al., UOG 2013 Discussion points • What is the optimal surveillance strategy in pregnancies diagnosed with TRAP sequence? • Should elective intrafetal therapy routinely be performed in all cases of TRAP sequence regardless of ultrasound findings? • If so, what is the optimal gestational age for treatment? • Would restricting the window of intrafetal laser treatment to 13-16 weeks’ gestation increase the risk of chorion-amnion separation? • What is the optimal surveillance strategy post-procedure? • Should care for TRAP pregnancies be centralized? • What is the long-term neurologic outcome for the surviving co-twin following intrafetal therapy for TRAP?

More Related